Business Description
Unicycive Therapeutics is a clinical-stage biotechnology company based in Los Altos, California, focused on developing new treatments for kidney disease and related conditions. Its two lead drug candidates target acute kidney injury and high phosphate levels in patients with chronic kidney disease. The company also pursues licensing partnerships to expand its portfolio into liver disease, metabolic disorders, and rare diseases involving inflammation and scarring.
